Introduction:Basic information about CAS 10302-78-0|2',3',5'-triacetyl-5-Azacytidine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 2',3',5'-triacetyl-5-Azacytidine |
|---|
| CAS Number | 10302-78-0 | Molecular Weight | 370.315 |
|---|
| Density | 1.6±0.1 g/cm3 | Boiling Point | 497.3±55.0 °C at 760 mmHg |
|---|
| Molecular Formula | C14H18N4O8 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 254.6±31.5 °C |
|---|
Names
| Name | 2',3',5'-Triacetyl -azacytidine |
|---|
| Synonym | More Synonyms |
|---|
2',3',5'-triacetyl-5-Azacytidine BiologicalActivity
| Description | 2′,3′,5′-Triacetyl-5-azacytidine is an orally active prodrug of 5-Azacytidine. 5-Azacytidine is an inhibitor of DNA methyltransferase[1]. |
|---|
| Related Catalog | Research Areas >>CancerSignaling Pathways >>Epigenetics >>DNA Methyltransferase |
|---|
| References | [1]. Ziemba A, et, al. Development of an oral form of azacytidine: 2'3'5'triacetyl-5-azacytidine. Chemother Res Pract. 2011;2011:965826. |
|---|
Chemical & Physical Properties
| Density | 1.6±0.1 g/cm3 |
|---|
| Boiling Point | 497.3±55.0 °C at 760 mmHg |
|---|
| Molecular Formula | C14H18N4O8 |
|---|
| Molecular Weight | 370.315 |
|---|
| Flash Point | 254.6±31.5 °C |
|---|
| Exact Mass | 370.112457 |
|---|
| PSA | 161.93000 |
|---|
| LogP | -0.60 |
|---|
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
|---|
| Index of Refraction | 1.634 |
|---|
| InChIKey | OTQJVHISAFFLMA-UHFFFAOYSA-N |
|---|
| SMILES | CC(=O)OCC1OC(n2cnc(N)nc2=O)C(OC(C)=O)C1OC(C)=O |
|---|
Synonyms
| 4-amino-1-(2,3,5-tri-O-acetylpentofuranosyl)-1,3,5-triazin-2(1H)-one |
| 2',3',5'-triacetyl-5-Azacytosine |
| 1,3,5-Triazin-2(1H)-one,4-amino-1-(2,3,5-tri-O-acetyl-b-D-ribofuranosyl) |
| 2,3,5-tri-O-acetyl-5-azacytidine |
| 5-azacytidine triacetate |
| 4-Amino-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one |
| 1,3,5-Triazin-2(1H)-one, 4-amino-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)- |
| 2',3',5'-triacetyl-5-azacytidine |